Precigen (PGEN) Liabilities and Shareholders Equity (2012 - 2026)

Precigen (PGEN) has 15 years of Liabilities and Shareholders Equity data on file, last reported at $138.6 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $138.6 million, up 7.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $567.3 million (up 31.72% YoY), and the FY2025 annual result was $155.5 million, up 7.05% from the prior year.
• Liabilities and Shareholders Equity eased to $138.6 million in Q1 2026 per PGEN's latest filing, from $155.5 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $335.6 million in Q1 2022 and troughed at $73.2 million in Q2 2024.
• A 5-year average of $179.7 million and a median of $155.5 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity sank 64.75% in 2024, then soared 105.17% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $216.0 million in 2022, then sank by 30.07% to $151.0 million in 2023, then slipped by 3.82% to $145.3 million in 2024, then gained by 7.05% to $155.5 million in 2025, then fell by 10.85% to $138.6 million in 2026.
• Business Quant data shows PGEN's Liabilities and Shareholders Equity at $138.6 million in Q1 2026, $155.5 million in Q4 2025, and $171.3 million in Q3 2025.